Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Research Progress of Electrically Conductive Asphalt Concrete Deicing and Snowmelt Technology: Material Development and Application Progress.

Sensors (Basel, Switzerland)·2026
Same author

Bergenin attenuates traumatic brain injury via inhibition of microglial PFKFB3-driven glycolytic-inflammatory crosstalk.

International immunopharmacology·2026
Same author

Highly Enantioselective Hydroxylation of 1-Indanone-Derived β-Ketoesters Catalyzed by a Newly Designed C1-Symmetric Salan-Zr Complex.

The Journal of organic chemistry·2026
Same author

A homemade and simple solid-state photoreactor for solvent-free benzylic oxidation.

Chemical communications (Cambridge, England)·2025
Same author

Iron-anthraquinone cooperative catalysis enables mild C-C bond cleavage of cyclohexanones <i>via</i> oxygen-centered radicals.

Chemical communications (Cambridge, England)·2025
Same author

Augmenting Antioxidant Enzyme-Like Activity and Hydrogen Evolution of MoS<sub>2</sub>@Bi<sub>2</sub>S<sub>3</sub> Heterojunction via Ultrasound-Evoked Piezoelectricity for Anti-Inflammation.

Small (Weinheim an der Bergstrasse, Germany)·2025

Related Experiment Video

Updated: Sep 18, 2025

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.3K

Transcriptomic analysis reveals novel targets in benign schwannoma using machine learning.

Suwei Yan1, Jingnan Zhao1, Pengyang Gao1

  • 1Department of Neurosurgery, Third Hospital of Hebei Medical University, Shijiazhuang 050051, China.

Neuroscience
|June 23, 2025
PubMed
Summary

Researchers identified five immune biomarkers for benign schwannoma using machine learning. These biomarkers offer insights into the tumor microenvironment and can aid in developing predictive models for disease evaluation and personalized treatments.

Keywords:
Benign SchwannomaBiomarkersMachine learningPredictive modelTherapeutic targetsTranscriptomic analysis

More Related Videos

A Unified Methodological Framework for Vestibular Schwannoma Research
08:43

A Unified Methodological Framework for Vestibular Schwannoma Research

Published on: June 20, 2017

7.5K
Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
10:58

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma

Published on: February 22, 2015

13.1K

Related Experiment Videos

Last Updated: Sep 18, 2025

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.3K
A Unified Methodological Framework for Vestibular Schwannoma Research
08:43

A Unified Methodological Framework for Vestibular Schwannoma Research

Published on: June 20, 2017

7.5K
Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
10:58

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma

Published on: February 22, 2015

13.1K

Area of Science:

  • Oncology
  • Immunology
  • Bioinformatics

Background:

  • Benign schwannoma is a nerve sheath tumor.
  • Understanding its immune microenvironment is crucial for diagnosis and treatment.

Purpose of the Study:

  • Identify key immune-related biomarkers for benign schwannoma.
  • Develop a predictive model for disease evaluation.

Main Methods:

  • Machine learning algorithms (LASSO, SVM, Random Forest) applied to transcriptomic data.
  • Immune subtyping and cell infiltration analysis.
  • Single-cell RNA sequencing (scRNA-seq) for biomarker validation.
  • In vitro and in vivo functional assays in an NF2-knockout mouse model.

Main Results:

  • Five novel immune-related biomarkers identified: ANGPTL1, IL17RC, LTBR, OLR1, and TGFBR1.
  • ANGPTL1 and IL17RC inhibited tumor progression; LTBR, OLR1, and TGFBR1 promoted it.
  • Biomarkers showed differential expression across immune subtypes and enrichment in tumor-associated immune cells.

Conclusions:

  • The identified biomarkers provide functional insights into benign schwannoma biology and its immune microenvironment.
  • A predictive model was developed, offering a foundation for risk stratification and personalized therapies.
  • These findings complement existing markers (NF2, SOX10, S100B) and suggest translational potential.